T-cell monitoring and immunotherapy for treating graft-versus-host disease

Manoj Menon

AMC PROTOCOL #075: A Sequential Phase I/Randomized Phase II Trial of Vorinostat and Risk-Adapted Chemotherapy with Rituximab in HIV-Related B-Cell Non-Hodgkin’s Lymphoma. A Trial of the AIDS Malignancy Consortium (AMC)

Hodgkin lymphoma

Hematology and hematologic malignancies

Franziska Michor

Evolution and Treatment Response of Brain, Breast, and Hematologic Malignancies

Non-Hodgkin lymphoma Leukaemia Hodgkin lymphoma

Eduardo M. Sotomayor

Role of Specific Histone Deacetylases in Lymphoma Immunobiology and Therapy

Hodgkin lymphoma Non-Hodgkin lymphoma

Oliver W. Press

Therapy of Lymphoma/Leukemia with Monoclonal Antibodies

Hodgkin lymphoma Leukaemia Non-Hodgkin lymphoma

Corey Casper

Uganda Cancer Institute / Hutchinson Center Cancer Alliance (UCI/HCCA)

Hodgkin lymphoma Non-Hodgkin lymphoma

Aude Chapuis

Targeting Leukemia with Memory CD8+ T cells Transduced to Express High-Affinity W

Leukaemia

Leslie Kean

American Society of Hematology's Project at the Angkor Hospital for Children in Siem Reap, Cambodia

Leukaemia

Pediatric oncology or childhood cancer Hematology and hematologic malignancies

Talya Salz

Do cardiovascular risk factors modify the cardiotoxicity of lymphoma treatments?

Non-Hodgkin lymphoma Hodgkin lymphoma

Martha Lassiter

Duke University Nursing Oncology Training Exchange with Tata Memorial Hospital

Hodgkin lymphoma Leukaemia Non-Hodgkin lymphoma